← Back to Search

Memory Training for Breast Cancer Survivors

N/A

Waitlist Available

Led By Elizabeth Ryan, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No evidence of disease at time of screening

Stage I, II, III breast cancer as noted in pathology reports or by clinician judgement

Must not have

History of neurological disorder with cognitive symptoms (e.g., Alzheimer's disease, Parkinson's disease, multiple sclerosis, seizure disorder) as per self report or as documented in the electronic medical record

History of Traumatic Brain Injury with > or = to 30 minutes loss of consciousness or cognitive sequelae as per self report or as documented in the medical record

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a memory training program for breast cancer survivors who have problems with memory after receiving chemotherapy.

Who is the study for?

This trial is for female breast cancer survivors aged 18-69 who've had chemotherapy 1-10 years ago and are currently disease-free. They must speak English, have basic computer skills, internet access, and show memory problems on specific tests. Excluded are those with significant past brain injury or cognitive issues from other conditions.

What is being tested?

The study evaluates a memory training program called Cogmed Working Memory Training to see if it improves memory and attention in breast cancer survivors post-chemotherapy. Participants will use either the standard software or a less challenging version randomly assigned.

What are the potential side effects?

Since this intervention involves cognitive exercises using software, side effects may be minimal but could include eye strain, headache, or frustration due to the difficulty of tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My current tests show no signs of cancer.

Select...

My breast cancer is at stage I, II, or III according to my doctor or pathology report.

Select...

I am between 18 and 69 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a neurological disorder like Alzheimer's, Parkinson's, MS, or epilepsy.

Select...

I have had a traumatic brain injury with significant loss of consciousness or lasting effects.

Select...

My cancer has come back.

Select...

I have had cancer before, but it was either basal cell carcinoma or melanoma treated with surgery only.

Select...

I have had a stroke, as confirmed by my own report or medical records.

Select...

I have undergone several rounds of chemotherapy.

Select...

I have a history of mental health or substance use disorders.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Determine the efficacy of working memory training

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Collateral sourceExperimental Treatment1 Intervention

Participants from both groups will be asked to complete two follow up neurocognitive assessments face to face at MSKCC. The first will be completed within 1-4 weeks after completing the memory training and the second will take place 3-4 months after completing the memory training. Collateral sources will be contacted at these same points to complete their brief assessments as well to test for maintenance of the treatment effect.

Group II: Breast cancer survivorsExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cogmed Working Memory Training Program

2008

N/A

~10

0 / 10Eligibility criteria met